Patients with a systemic rheumatic disease hospitalized with COVID-19 may be at increased risk for severe outcomes, including hyperinflammation, kidney injury, admission to the intensive care unit (ICU), and mechanical ventilation, according to study results published in the Lancet Rheumatology. Previous studies have shown that excessive inflammation may be associated with risk for poor outcomes in patients with COVID-19.